153 related articles for article (PubMed ID: 38223669)
1. Comparative metabolism of fargesin in human, dog, monkey, mouse, and rat hepatocytes.
Lee MS; Park EJ; Cho YY; Lee JY; Kang HC; Lee HS
Toxicol Res; 2024 Jan; 40(1):125-137. PubMed ID: 38223669
[TBL] [Abstract][Full Text] [Related]
2. Comparative metabolism of aschantin in human and animal hepatocytes.
Lee MS; Shim HJ; Cho YY; Lee JY; Kang HC; Song IS; Lee HS
Arch Pharm Res; 2024 Feb; 47(2):111-126. PubMed ID: 38182943
[TBL] [Abstract][Full Text] [Related]
3. Multiple UDP-Glucuronosyltransferase and Sulfotransferase Enzymes are Responsible for the Metabolism of Verproside in Human Liver Preparations.
Kim JH; Hwang DK; Moon JY; Lee Y; Yoo JS; Shin DH; Lee HS
Molecules; 2017 Apr; 22(4):. PubMed ID: 28441724
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Metabolism of DWP16001, a Novel Sodium-Glucose Cotransporter 2 Inhibitor, in Human and Animal Hepatocytes.
Kim JH; Kim DK; Choi WG; Ji HY; Choi JS; Song IS; Lee S; Lee HS
Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32932946
[TBL] [Abstract][Full Text] [Related]
5. Role of cytochrome P450 and UDP-glucuronosyltransferases in metabolic pathway of homoegonol in human liver microsomes.
Kwon SS; Kim JH; Jeong HU; Ahn KS; Oh SR; Lee HS
Drug Metab Pharmacokinet; 2015 Aug; 30(4):305-13. PubMed ID: 26163112
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes.
Kim JH; Kwon SS; Jeong HU; Lee HS
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468305
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
Wu WN; McKown LA; Reitz AB
Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
[TBL] [Abstract][Full Text] [Related]
8. Identification of Catalposide Metabolites in Human Liver and Intestinal Preparations and Characterization of the Relevant Sulfotransferase, UDP-glucuronosyltransferase, and Carboxylesterase Enzymes.
Hwang DK; Kim JH; Shin Y; Choi WG; Kim S; Cho YY; Lee JY; Kang HC; Lee HS
Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31336576
[TBL] [Abstract][Full Text] [Related]
9. In vitro metabolism of l-corydalmine, a potent analgesic drug, in human, cynomolgus monkey, beagle dog, rat and mouse liver microsomes.
Tang X; Di X; Zhong Z; Xie Q; Chen Y; Wang F; Ling Z; Xu P; Zhao K; Wang Z; Liu L; Liu X
J Pharm Biomed Anal; 2016 Sep; 128():98-105. PubMed ID: 27239758
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450-mediated metabolism of triclosan attenuates its cytotoxicity in hepatic cells.
Wu Y; Chitranshi P; Loukotková L; Gamboa da Costa G; Beland FA; Zhang J; Fang JL
Arch Toxicol; 2017 Jun; 91(6):2405-2423. PubMed ID: 27896399
[TBL] [Abstract][Full Text] [Related]
11. In vitro metabolism of magnolin and characterization of cytochrome P450 enzymes responsible for its metabolism in human liver microsomes.
Kim DK; Liu KH; Jeong JH; Ji HY; Oh SR; Lee HK; Lee HS
Xenobiotica; 2011 May; 41(5):358-71. PubMed ID: 21294626
[TBL] [Abstract][Full Text] [Related]
12. CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide.
Bidstrup TB; Bjørnsdottir I; Sidelmann UG; Thomsen MS; Hansen KT
Br J Clin Pharmacol; 2003 Sep; 56(3):305-14. PubMed ID: 12919179
[TBL] [Abstract][Full Text] [Related]
13. Curcuminoids inhibit multiple human cytochromes P450, UDP-glucuronosyltransferase, and sulfotransferase enzymes, whereas piperine is a relatively selective CYP3A4 inhibitor.
Volak LP; Ghirmai S; Cashman JR; Court MH
Drug Metab Dispos; 2008 Aug; 36(8):1594-605. PubMed ID: 18480186
[TBL] [Abstract][Full Text] [Related]
14. In vitro metabolism of eupatilin by multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes.
Lee HS; Ji HY; Park EJ; Kim SY
Xenobiotica; 2007 Aug; 37(8):803-17. PubMed ID: 17701830
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Characterization of Ertugliflozin Metabolism by UDP-Glucuronosyltransferase and Cytochrome P450 Enzymes.
Lapham K; Callegari E; Cianfrogna J; Lin J; Niosi M; Orozco CC; Sharma R; Goosen TC
Drug Metab Dispos; 2020 Dec; 48(12):1350-1363. PubMed ID: 33020067
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Metabolism of 25B-NBF, 2-(4-Bromo-2,5-Dimethoxyphenyl)-
Kim JH; Kim S; Lee J; In S; Cho YY; Kang HC; Lee JY; Lee HS
Molecules; 2019 Feb; 24(4):. PubMed ID: 30823561
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Metabolic Pathways of the New Anti-Diabetic Drug Evogliptin in Human Liver Preparations.
Jeong HU; Kim JH; Lee DY; Shim HJ; Lee HS
Molecules; 2015 Dec; 20(12):21802-15. PubMed ID: 26690104
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of MK-0524, a prostaglandin D2 receptor 1 antagonist, in microsomes and hepatocytes from preclinical species and humans.
Dean BJ; Chang S; Silva Elipe MV; Xia YQ; Braun M; Soli E; Zhao Y; Franklin RB; Karanam B
Drug Metab Dispos; 2007 Feb; 35(2):283-92. PubMed ID: 17132765
[TBL] [Abstract][Full Text] [Related]
19. Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.
Gröer C; Busch D; Patrzyk M; Beyer K; Busemann A; Heidecke CD; Drozdzik M; Siegmund W; Oswald S
J Pharm Biomed Anal; 2014 Nov; 100():393-401. PubMed ID: 25218440
[TBL] [Abstract][Full Text] [Related]
20. In vitro biotransformation of a novel antimalarial cysteine protease inhibitor in human liver microsomes.
Zhang Y; Guo X; Lin ET; Benet LZ
Pharmacology; 1999 Mar; 58(3):147-59. PubMed ID: 9925971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
